In a June 21 hiring announcement, the Princeton-based life sciences company said Daniels Knight brings more than 30 years’ experience to the role. “Lea brings a wealth of finance, accounting, and ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Integra Lifesciences ( (IART)) just ...

In the last three months, 8 analysts have published ratings on Integra Lifesciences (NASDAQ:IART), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed ...

Integra LifeSciences (IART) continues to face operational and execution challenges, with shares underperforming and ...

Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported first-quarter revenues of $368.9 million, down 3.1% Y/Y on a reported basis and 2.5% on an organic basis, beating the consensus ...

BRAINTREE – A leading life sciences company says it might relocate to Wood Road in Braintree because it has outgrown its South Boston manufacturing plant and has no room to expand. Integra ...

When InvestingPro's Fair Value models identified Integra LifeSciences (NASDAQ:IART) as significantly undervalued in September 2024, the healthcare company's stock was trading near its 52-week low. The ...

Princeton-based Integra LifeSciences Holdings Corp., a global medical technology company, on Dec. 11 hosted a ribbon-cutting ceremony to celebrate its 30th anniversary and the opening of its new ...

Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 23% in the morning session after it reported third-quarter sales that missed expectations and provided a weak financial outlook ...

Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for. Integra LifeSciences beat analysts’ revenue expectations ...

Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for. Integra LifeSciences met analysts’ revenue expectations ...

Shares fell after the company's second-quarter results came up short of expectations. Revenue grew 13% to $282.2 million for the quarter. That figure was a hair shy of the $282.9 million that Wall ...